Mercer's Q3 2026 EBITDA Narrows to -$2.9M, But Still Negative

What happened

Mercer International reported Q3 2026 Operating EBITDA of negative $2.9 million, a sharp sequential improvement from negative $21.0 million in Q2 2026 and negative $28.1 million a year earlier. The improvement likely reflects contributions from the 'One Goal One Hundred' cost program and modest pulp price stabilization, though the company has not disclosed segment details or one-time items in this release. Despite the narrower loss, Mercer remains cash-flow negative at the operating level before heavy interest expense of roughly $85 million per nine months on its high-coupon debt. The press release also omits critical data on liquidity, covenant headroom and free cash flow, leaving investors unable to assess whether the improvement is durable or partly accounting-driven. Investors should view this as evidence of progress toward breakeven but not yet confirmation of a self-sustaining financial position.

Implication

Investors should acknowledge that the Q3 2026 result marks real progress: the operating loss narrowed to less than one-tenth of year-ago levels and nearly to zero. However, with interest costs still consuming roughly $85 million per nine months, even a small EBITDA deficit can lead to continuing cash outflows and pressure on the ~$376 million liquidity buffer last disclosed. The lack of segment and cash-flow detail in the release makes it impossible to determine if the improvement is from sustainable cost reductions or from temporary factors such as inventory gains or favorable FX. A hold or wait approach remains appropriate until Mercer posts at least one quarter of positive EBITDA and provides updated liquidity and covenant data. Only after those confirmations would the risk-reward justify considering an entry near $2.00–$3.00, and even then size should reflect the high leverage and commodity exposure.

Thesis delta

The thesis incrementally improves but remains cautious. The EBITDA trajectory is moving close to breakeven, consistent with the base case of modestly positive EBITDA by 2026, but the company has not yet demonstrated positive operating cash generation. Maintain WAIT until a full quarter of positive EBITDA, improved liquidity disclosure, and evidence that cost savings are recurring.